The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2006

Filed:

Oct. 27, 1999
Applicants:

Paolo Pevarello, Pavia, IT;

Raffaella Amici, Piacenza, IT;

Gabriella Traquandi, Milan, IT;

Manuela Villa, Lurago d'Erba, IT;

Anna Vulpetti, Brugherio, IT;

Antonella Isacchi, Milan, IT;

Inventors:

Paolo Pevarello, Pavia, IT;

Raffaella Amici, Piacenza, IT;

Gabriella Traquandi, Milan, IT;

Manuela Villa, Lurago d'Erba, IT;

Anna Vulpetti, Brugherio, IT;

Antonella Isacchi, Milan, IT;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/426 (2006.01); A61K 31/495 (2006.01); C07D 277/20 (2006.01); C07D 413/02 (2006.01); C07D 417/02 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds which are 2-amino-1,3-thiazole derivatives of formula (I)wherein R is a halogen atom, a nitro group, an optionally substituted amino group or it is a group, optionally further substituted, selected from i) straight or branched C–Calkyl, C–Calkenyl or C–Calkynyl; ii) C–Ccycloalkyl; iii) aryl or arylalkyl with from 1 to 8 carbon atoms within the straight or branched alkyl chain; Ris an optionally further substituted group selected from: i) straight or branched C–Calkyl or C–Calkenyl; ii) 3 to 6 membered carbocycle or 5 to 7 membered heterocycle ring; iii) aryl or arylcarbonyl; iv) arylalkyl with from 1 to 8 carbon atoms within the straight or branched alkyl chain; v) arylalkenyl with from 2 to 6 carbon atoms within the straight or branched alkenyl chain; vi) an optionally protected amino acid residue; or a pharmaceutically acceptable salt thereof; are useful for treating cell proliferative disorders associated with an altered cell dependent kinase activity.


Find Patent Forward Citations

Loading…